Yunn‐Yi Chen

4.6k total citations
58 papers, 2.3k citations indexed

About

Yunn‐Yi Chen is a scholar working on Cancer Research, Pathology and Forensic Medicine and Dermatology. According to data from OpenAlex, Yunn‐Yi Chen has authored 58 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Cancer Research, 25 papers in Pathology and Forensic Medicine and 17 papers in Dermatology. Recurrent topics in Yunn‐Yi Chen's work include Breast Lesions and Carcinomas (23 papers), Breast Cancer Treatment Studies (22 papers) and Cancer and Skin Lesions (17 papers). Yunn‐Yi Chen is often cited by papers focused on Breast Lesions and Carcinomas (23 papers), Breast Cancer Treatment Studies (22 papers) and Cancer and Skin Lesions (17 papers). Yunn‐Yi Chen collaborates with scholars based in United States, Australia and Canada. Yunn‐Yi Chen's co-authors include Gregor Krings, Joseph T. Rabban, Stuart J. Schnitt, Jonathan N. Glickman, Robert D. Odze, Gregory R. Bean, Patrick L. Fitzgibbons, Helen H. Wang, Brian Lee and Hui Zhang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Yunn‐Yi Chen

58 papers receiving 2.3k citations

Peers

Countries citing papers authored by Yunn‐Yi Chen

Since Specialization

Citations

This map shows the geographic impact of Yunn‐Yi Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yunn‐Yi Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yunn‐Yi Chen more than expected).

Fields of papers citing papers by Yunn‐Yi Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yunn‐Yi Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yunn‐Yi Chen. The network helps show where Yunn‐Yi Chen may publish in the future.

Co-authorship network of co-authors of Yunn‐Yi Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Yunn‐Yi Chen. A scholar is included among the top collaborators of Yunn‐Yi Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yunn‐Yi Chen. Yunn‐Yi Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Therapeutic response and outcomes with uncommon breast cancer subtypes in the I-SPY trial 2010-2022. 2024 ·Journal of Clinical Oncology ·Alexandra Thomas, Denise M. Wolf, Ronald Balassanian, Yunn‐Yi Chen, (unknown), Poonam Vohra, Evin Gulbahce, Alexander D. Borowsky, Lamorna Brown Swigart, Gillian L. Hirst, Sara J. Venters, Rita Nanda, Rebecca Shatsky, Ralph B. D’Agostino, Rita A. Mukhtar, (unknown), Christina Yau, Angela DeMichele, Laura van ‘t Veer, Laura J. Esserman	1
2	Management of Concurrent Malignant Phyllodes Tumor and Invasive Breast Carcinoma 2024 ·Advances in Radiation Oncology ·(unknown), (unknown), A. Patel, Gregor Krings, Yunn‐Yi Chen, (unknown), Rita A. Mukhtar, Michelle Melisko, Lisa Singer, Catherine C. Park, Nicolas D. Prionas	2
3	Targeted DNA Sequencing in Diagnosis of Malignant Phyllodes Tumors With Emphasis on Tumors With Keratin and p63 Expression 2024 ·Modern Pathology ·(unknown), (unknown), Gregory R. Bean, (unknown), Christopher J. Schwartz, Poonam Vohra, (unknown), Aihui Wang, Elizabeth M. Hosfield, Yan Peng, Yunn‐Yi Chen, Gregor Krings	6
4	Solid-Basaloid Adenoid Cystic Carcinoma of the Breast: An Aggressive Subtype Enriched for Notch Pathway and Chromatin Modifier Mutations With MYB Overexpression 2023 ·Modern Pathology ·Eliah R. Shamir, Gregory R. Bean, Christopher J. Schwartz, Poonam Vohra, Aihui Wang, (unknown), Rebecca J. Wolsky, Joaquín J. García, Yunn‐Yi Chen, Gregor Krings	6
5	Triple-Negative Apocrine Carcinomas: Toward a Unified Group With Shared Molecular Features and Clinical Behavior 2023 ·Modern Pathology ·Christopher J. Schwartz, (unknown), Gregory R. Bean, Deepika Sirohi, Nancy M. Joseph, Elizabeth M. Hosfield, Timothy W. Jacobs, Rita A. Mukhtar, Yunn‐Yi Chen, Gregor Krings	14
6	HER2 IHC Expression and Gene Amplification in p53-aberrant High-grade Endometrial Endometrioid Carcinoma Suggests That This Population May Benefit From HER2 Testing and Targeted Therapy 2023 ·The American Journal of Surgical Pathology ·Amy Joehlin‐Price, (unknown), (unknown), Patrick J. Devine, (unknown), (unknown), (unknown), Caroline Astbury, Raza S. Hoda, Yunn‐Yi Chen, Karuna Garg	13
7	Genetic and Immunohistochemical Profiling of Mammary Hidradenoma and Comparison to Mucoepidermoid Carcinoma 2023 ·Modern Pathology ·Margaret A. Black, Neil M. Neumann, Gregor Krings, (unknown), Megan L. Troxell, Aihui Wang, W. Patrick Devine, Poonam Vohra, (unknown), Yunn‐Yi Chen, Jarish N. Cohen, Gregory R. Bean	8
8	Molecular analysis of TCGA breast cancer histologic types 2021 ·Cell Genomics ·Aatish Thennavan, Francisco Beça, (unknown), Susana García‐Recio, Kimberly H. Allison, Laura C. Collins, Gary M. Tse, Yunn‐Yi Chen, Stuart J. Schnitt, Katherine A. Hoadley, Andrew H. Beck, Charles M. Perou	62
9	Matrix compliance permits NF-κB activation to drive therapy resistance in breast cancer 2021 ·The Journal of Experimental Medicine ·Allison P. Drain, Nastaran Zahir, Jason J. Northey, Hui Zhang, Po‐Jui Huang, Ori Maller, Johnathon N. Lakins, Xinmiao Yu, Jennifer L. Leight, Brenda Alston‐Mills, E. Shelley Hwang, Yunn‐Yi Chen, Catherine C. Park, Valerie M. Weaver	45
10	Primary mammary angiosarcomas harbor frequent mutations in KDR and PIK3CA and show evidence of distinct pathogenesis 2020 ·Modern Pathology ·Francisco Beça, Gregor Krings, Yunn‐Yi Chen, Elizabeth M. Hosfield, Poonam Vohra, Richard K. Sibley, Megan L. Troxell, Robert B. West, Kimberly H. Allison, Gregory R. Bean	19
11	Genetic analysis of pleomorphic and florid lobular carcinoma in situ variants: frequent ERBB2/ERBB3 alterations and clonal relationship to classic lobular carcinoma in situ and invasive lobular carcinoma 2020 ·Modern Pathology ·Eliah R. Shamir, Yunn‐Yi Chen, Gregor Krings	13
12	‘Non-classical’ HER2 FISH results in breast cancer: a multi-institutional study 2016 ·Modern Pathology ·(unknown), Florencia G. Jalikis, Gregor Krings, Rodney A. Schmidt, Yunn‐Yi Chen, Mara H. Rendi, Suzanne M. Dintzis, Kristin C. Jensen, Robert B. West, Richard K. Sibley, Megan L. Troxell, Kimberly H. Allison	68
13	“Score the Core” Web-based pathologist training tool improves the accuracy of breast cancer IHC4 scoring 2015 ·Human Pathology ·Jesse A. Engelberg, Hanna Retallack, Ronald Balassanian, Mitch Dowsett, Lila Zabaglo, (unknown), Sophia K. Apple, John W. Bishop, Alexander D. Borowsky, Philip M. Carpenter, Yunn‐Yi Chen, Brian Datnow, Sarah L. Elson, Farnaz Hasteh, Fritz Lin, Neda A. Moatamed, Yanhong Zhang, Robert D. Cardiff	11
14	Force Engages Vinculin and Promotes Tumor Progression by Enhancing PI3K Activation of Phosphatidylinositol (3,4,5)-Triphosphate 2014 ·Cancer Research ·Matthew G. Rubashkin, Luke Cassereau, Russell Bainer, Christopher C. DuFort, Yoshihiro Yui, Guanqing Ou, Matthew J. Paszek, Michael W. Davidson, Yunn‐Yi Chen, Valerie M. Weaver	163
15	Diagnostic utility and sensitivities of GATA3 antibodies in triple-negative breast cancer 2014 ·Human Pathology ·Gregor Krings, (unknown), (unknown), Poonam Vohra, Yunn‐Yi Chen	72
16	Mammographic density and risk of breast cancer by age and tumor characteristics 2013 ·Breast Cancer Research ·Kimberly A. Bertrand, Rulla M. Tamimi, Christopher G. Scott, Matthew R. Jensen, V. Shane Pankratz, Daniel W. Visscher, Aaron D. Norman, Fergus J. Couch, John Shepherd, Bo Fan, Yunn‐Yi Chen, Lin Ma, Andrew H. Beck, Steven R. Cummings, Karla Kerlikowske, Celine M. Vachon	141
17	Protocol for the Examination of Specimens From Patients With Ductal Carcinoma In Situ of the Breast 2009 ·Archives of Pathology & Laboratory Medicine ·Susan C. Lester, Shikha Bose, Yunn‐Yi Chen, James L. Connolly, Monica E. de Baca, Patrick L. Fitzgibbons, Daniel F. Hayes, Celina Kleer, Frances P. O’Malley, David L. Page, Barbara L. Smith, Donald L. Weaver, Eric P. Winer	99
18	Genetic and Phenotypic Characteristics of Pleomorphic Lobular Carcinoma In Situ of the Breast 2009 ·The American Journal of Surgical Pathology ·Yunn‐Yi Chen, Eun-Sil Shelley Hwang, Ritu Roy, Sandy DeVries, Joseph Anderson, (unknown), Patrick L. Fitzgibbons, Timothy W. Jacobs, Gaëtan MacGrogan, Hans Peterse, Anne Vincent‐Salomon, Taku A. Tokuyasu, Stuart J. Schnitt, Frederic M. Waldman	96
19	Fibroepithelial Lesions With Cellular Stroma on Breast Core Needle Biopsy: Are There Predictors of Outcome on Surgical Excision? 2005 ·American Journal of Clinical Pathology ·Timothy W. Jacobs, Yunn‐Yi Chen, Donald G. Guinee, Joseph A. Holden, Imok Cha, Donald E. Bauermeister, Beverly E. Hashimoto, Dulcy Wolverton, (unknown)	62
20	Phenotypic Characteristics of a Distinctive Multilayered Epithelium Suggests That It Is a Precursor in the Development of Barrett's Esophagus 2001 ·The American Journal of Surgical Pathology ·Jonathan N. Glickman, Yunn‐Yi Chen, Helen H. Wang, (unknown), Robert D. Odze	149

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact